Compositions and methods of use for antibodies of c-Met

Details for Australian Patent Application No. 2011203499 (hide)

Owner Novartis AG

Inventors Brocks, Bodo; Prassler, Josef; Stover, David Raymond; Berger, Catrin

Agent Davies Collison Cave

Pub. Number AU-A-2011203499

Parent 2007245181

Filing date 11 July 2011

Wipo publication date 28 July 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/00 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

G01N 33/00 (2006.01) Investigating or analysing materials by specific methods not covered by groups

Event Publications

28 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203499

28 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203500-Apparatus and method for producing hydrogen

2011203498-Wheel Chock System